philipn / TRV027 3867d76f46c31afe63ddd152f09123f8556b5f66

Create Draft
Starting
Review changes View this version of the page
You can also use the and keys
Deletions are marked like this Additions are marked like this

TRV027 is a biased agonist of the AT1 receptor currently in development by Trevena, Inc.  It is being trialed as a drug to treat COVID-19.

See also
Create Draft
Contributed by
Except where otherwise noted, text content is licensed under a Creative Commons Attribution-ShareAlike License. See copyright information.